Science ❯Medical Research ❯Clinical Trials
Regulatory T Cells Oncology Immunotherapy Drugs Schizophrenia Treatments Monoclonal Antibodies Health Outcomes Innovative Therapies FDA Approvals HIV Research NRTIs and Alzheimer's Historical Context Larazotide
The phase IIa trial demonstrated rapid gastrointestinal symptom resolution alongside complete spike antigen clearance by day 21 in children treated with larazotide.